Insulin

1. Overview

Insulin is a peptide hormone essential for regulating blood glucose levels and overall energy metabolism. It facilitates the uptake of glucose by cells and promotes the storage of nutrients in the form of glycogen, fat, and protein. Insulin is the primary anabolic hormone of the body and serves as a counter-regulatory hormone to glucagon. It plays a central role in maintaining homeostasis, especially after food intake.

2. Location

Insulin is synthesized and secreted by the beta (β) cells of the islets of Langerhans in the pancreas. The pancreas is a mixed gland located in the upper abdomen, with both exocrine and endocrine functions. The islets are clusters of endocrine cells scattered throughout the pancreas, with beta cells constituting approximately 60–70% of the islet population.

3. Structure

Insulin is a peptide hormone composed of two polypeptide chains:

• A chain: 21 amino acids

• B chain: 30 amino acids

These chains are connected by two disulfide bridges. Insulin is initially synthesized as preproinsulin, which is processed in the endoplasmic reticulum to proinsulin, and then cleaved in the Golgi apparatus to yield mature insulin and C-peptide. Insulin is water-soluble and acts via the insulin receptor, a transmembrane tyrosine kinase receptor.

4. Function

Insulin facilitates the storage and utilization of glucose, lipids, and amino acids:

• Promotes glucose uptake in insulin-sensitive tissues (e.g., muscle, adipose) via upregulation of GLUT4 transporters.

• Stimulates glycogenesis in liver and skeletal muscle.

• Inhibits gluconeogenesis and glycogenolysis in the liver.

• Enhances lipogenesis and inhibits lipolysis in adipose tissue.

• Stimulates protein synthesis and inhibits proteolysis in muscle and other tissues.

5. Physiological role(s)

Insulin plays a central role in maintaining metabolic homeostasis:

• Postprandial glucose regulation: Insulin levels rise after meals to reduce blood glucose by promoting its uptake and storage.

• Energy storage: Facilitates conversion of excess glucose to glycogen or fat for later use.

• Anabolic functions: Supports growth and tissue repair by promoting protein and lipid synthesis.

• Electrolyte balance: Promotes potassium uptake into cells, influencing serum potassium levels.

• Fetal growth: In the fetus, insulin functions as a growth hormone, contributing to normal development.

6. Clinical Significance

Dysregulation of insulin production or action is central to many metabolic disorders:

• Type 1 Diabetes Mellitus (T1DM):

  • Caused by autoimmune destruction of pancreatic beta cells, resulting in absolute insulin deficiency.

  • Presents with hyperglycemia, polyuria, polydipsia, weight loss, and risk of diabetic ketoacidosis (DKA).

  • Treatment requires lifelong exogenous insulin therapy.

• Type 2 Diabetes Mellitus (T2DM):

  • Characterized by insulin resistance and relative insulin deficiency.

  • Associated with obesity, metabolic syndrome, and physical inactivity.

  • Managed with lifestyle changes, oral hypoglycemics, and insulin when needed.

• Hyperinsulinemia:

  • Often seen in early T2DM and insulin resistance states.

  • Can promote weight gain and contribute to atherosclerosis.

• Insulinoma:

  • A rare beta-cell tumor that secretes excess insulin, leading to recurrent episodes of hypoglycemia.

  • Treated surgically or medically using diazoxide or somatostatin analogs.

• Hypoglycemia:

  • May result from excessive insulin administration, especially in diabetics.

  • Symptoms include tremors, confusion, sweating, seizures, and potential loss of consciousness.

• Insulin therapy:

  • Various insulin formulations are used (rapid-acting, short-acting, intermediate, long-acting) to mimic physiological insulin secretion.

  • Essential in managing T1DM and advanced T2DM.